Eniko Toke

Co-founder, CSO at Treos Bio

Presenter

Dr. Enikő Tőke is a Co-Founder of Treos Bio and co-inventor of all Treos Bio proprietary patents. She brings more than 20 years of interdisciplinary experience in translational biomedical research, with a particular focus on the development of immunotherapies across oncology, infectious diseases and allergy. Dr. Tőke has played a central scientific role in the discovery and development of novel active immunotherapy platforms, including Langerhans cell-targeting immunotherapies, advanced nanomedicine delivery systems, pharmaceutically acceptable polymer technologies (novel excipients), and medical devices. Multiple programs originating from her research have progressed into clinical-stage drug development. She is the lead author of numerous peer-reviewed scientific publications and is a regular presenter at international scientific conferences. Her work spans early discovery through clinical development, bridging academic innovation and industry execution. Dr. Tőke holds a PhD from the Budapest University of Technology and Economics (Hungary) and an MSc in Biochemical Engineering from Babes-Bolyai University, Cluj-Napoca (Romania).